Status:
COMPLETED
A Bioequivalence Study of Tobradex AF
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.
Eligibility Criteria
Inclusion
- 18 or older
- Other protocol-defined inclusion criteria may apply
Exclusion
- Under 18
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
995 Patients enrolled
Trial Details
Trial ID
NCT00362895
Start Date
April 1 2006
End Date
August 1 2006
Last Update
March 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon for Trial Location(s)
Fort Worth, Texas, United States, 76134